In the analysis of 5,605 cases of breast cancer, ERBB2 was altered in 12.5% of all genes, with 10.6% of amplifications, 2.4% of mutation, and 0.7% of the combination of amplification and mutation (6). The gene discussed is ERBB2; the disease is breast carcinoma.